Metabolic tumor burden as marker of outcome in advanced EGFR wild-type NSCLC patients treated with erlotinib

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

E. Eisenhauer, P. Therasse, Jan Bogaerts et al. · European Journal of Cancer · 2008 · 29.5K citations

Medicine, Oncology, Treatment Planning +14

Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Solange Peters, Alex A. Adjei, Cesare Gridelli et al. · Annals of Oncology · 2012 · 928 citations · Full text

Medicine, Cancer Biology, Oncology +14

Non-Small Cell Lung Cancer

Elsevier eBooks · 2016 · 859 citations

Medicine, Oncology, Oncology Nursing +15

Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

Gregory A. Masters, Sarah Temin, Christopher G. Azzoli et al. · Journal of Clinical Oncology · 2015 · 851 citations

Medicine, Oncology, Chemotherapy +12

Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Martin Reck, Sanjay Popat, Niels Reinmuth et al. · Annals of Oncology · 2014 · 679 citations

Medicine, Cancer Biology, Oncology +14